Status:
ACTIVE_NOT_RECRUITING
Tissue Engineering Approaches to Treat COPD
Lead Sponsor:
University Hospitals of North Midlands NHS Trust
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study is a pilot/laboratory study comparing lung tissue from control participants with tissue from COPD participants with a chronic bronchitis or emphysema phenotypes. Tissue will be characterised...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is currently ranked as the third leading cause of death with an annual associated global healthcare cost of £1.3 trillion (1). It is the second most common...
Eligibility Criteria
Inclusion
- Men or women aged over 18 years- .
- Must be competent to give written informed consent.
- Scheduled to undergo clinical indicated surgery to remove lung tissue.
Exclusion
- Patient unable to give informed consent
- Significant long term condition or lung pathology (infection, asthma, fibrotic lung diseases) other than that for which they have been referred for surgery.
- Post Surgery
- • Insufficient tissue removed to supply the laboratory study after consultation with the Consultant histopathologist.
Key Trial Info
Start Date :
August 31 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04878445
Start Date
August 31 2017
End Date
December 31 2025
Last Update
February 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of North Midlands NHS Trust
Stoke-on-Trent, Staffordshire, United Kingdom, ST4 6QG